Integrating 4 methods to evaluate physical function in patients with cancer (In4M): protocol for a prospective cohort study.
Saved in:
| Title: | Integrating 4 methods to evaluate physical function in patients with cancer (In4M): protocol for a prospective cohort study. |
|---|---|
| Authors: | Thanarajasingam G; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA thanarajasingam.gita@mayo.edu., Kluetz P; US Food and Drug Administration, Silver Spring, Maryland, USA., Bhatnagar V; US Food and Drug Administration, Silver Spring, Maryland, USA., Brown A; Health Education and Content Services, Mayo Clinic, Rochester, Minnesota, USA., Cathcart-Rake E; Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA., Diamond M; US Food and Drug Administration, Silver Spring, Maryland, USA., Faust L; Division of Health Care Delivery Research, Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA., Fiero MH; US Food and Drug Administration, Silver Spring, Maryland, USA., Huntington S; Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.; Yale's Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale School of Medicine, New Haven, Connecticut, USA., Jeffery MM; Division of Health Care Delivery Research and Department of Emergency Medicine, Mayo Clinic, Rochester, Minnesota, USA.; Department of Emergency Medicine, Mayo Clinic, Rochester, Minnesota, USA., Jones L; Patient Advocate, Arlington, Virginia, USA., Noble B; Department of Quantitative Health Sciences, Mayo Clinic, Phoenix, Arizona, USA., Paludo J; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA., Powers B; CancerHacker Lab, Boston, Massachusetts, USA., Ross JS; Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.; Yale-New Haven Center for Outcomes Research and Evaluation (CORE), Yale School of Medicine, New Haven, Connecticut, USA.; Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut, USA., Ritchie JD; Yale-New Haven Center for Outcomes Research and Evaluation (CORE), Yale School of Medicine, New Haven, Connecticut, USA., Ruddy K; Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA., Schellhorn S; Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.; Yale's Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale School of Medicine, New Haven, Connecticut, USA., Tarver M; US Food and Drug Administration, Silver Spring, Maryland, USA., Dueck AC; Department of Quantitative Health Sciences, Mayo Clinic, Phoenix, Arizona, USA., Gross C; Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.; Yale's Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale School of Medicine, New Haven, Connecticut, USA.; Yale-New Haven Center for Outcomes Research and Evaluation (CORE), Yale School of Medicine, New Haven, Connecticut, USA.; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut, USA. |
| Source: | BMJ open [BMJ Open] 2024 Jan 10; Vol. 14 (1), pp. e074030. Date of Electronic Publication: 2024 Jan 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
